Mirum Pharmaceuticals (MIRM) PT Raised to $146 at Citizens After ENDO Data Reveal

June 15, 2026 5:20 AM

Citizens analyst Jonathan Wolleben raised the price target on Mirum Pharmaceuticals (NASDAQ: MIRM) to $146.00 (from $140.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found